In addition, when analysing CellMiner data, we also found that high expression of SERPINC1 can contribute to resistance to multiple drug therapies in colon cancer patients, such as oxaliplatin, fenvelamine and nelarabine. The gene discussed is SERPINC1; the disease is colonic neoplasm.